Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Thomas Grader-Beck"'
Autor:
David Thompson, Richard Moore, Elizabeth Holmes, Thomas Grader-Beck, Walid El-Nahal, Kelly Gebo, Kayla Herne, Stephen Berry
Publikováno v:
BMJ Health & Care Informatics, Vol 29, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/06e20e236da74a8ebb46d7e644ec7539
Autor:
Dipal M. Patel, Sumeska Thavarajah, Jack Bitzel, Thomas Grader-Beck, Derek M. Fine, Morgan E. Grams, Chirag R. Parikh, Deidra C. Crews
Publikováno v:
Clinical Journal of the American Society of Nephrology.
Publikováno v:
J Rheumatol
ObjectiveSjögren syndrome (SS) has a significant impact on health-related quality of life (HRQOL). We sought to evaluate how the Patient Reported Outcome Measurement Information System (PROMIS) domains in SS may supplement the European League Agains
Publikováno v:
Arthritis Care & Research. 74:151-160
Objective To assess the interchangeability of the Health Assessment Questionnaire-Disability Index (HAQ-DI) with the Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF) in the calculation of minimal disease activity
Publikováno v:
Arthritis Care Res (Hoboken)
Objective To evaluate the safety and utility of core needle biopsy (CNB) for diagnosis of salivary gland lymphoma in Sjogren's syndrome (SS). Methods We analyzed data from consecutive SS patients who underwent ultrasound-guided major salivary gland C
Autor:
Scott M. Lieberman, Kristin M. Burkart, Kerry L. Neall, Schartess Culpepper Pace, Apostolos Kontzias, Judith A. Furlong, Morgan I. Soffler, Rahul G. Argula, Maria Danila, Mark H. Adelman, Joseph Barney, Lynn M. Petruzzi, Matthew C. Baker, Charles D. Burger, Chadwick R. Johr, Elliot Rosenstein, Robert Vassallo, Stephen Doyle, Gregory P. Downey, Gretchen Winter, Thomas Eckmann, Jeanne Dale, Richard A. Helmers, Stanley Pillemer, Alan Baer, Tamiko Katsumoto, Keith J. Robinson, Amit Sachdev, Robert M. Kotloff, Vasileios C. Kyttaris, Rendell W. Ashton, Rachana Krishna, Sara S. McCoy, Nora Sandorfi, Kristin A. Riekert, Stamatina J. Danielides, Elizabeth R. Volkmann, Heidi Kukla, Timothy Niewold, Donald Bloch, Jennifer W. McCallister, Michelle Sharp, Jerome L. Greene, Robert I. Fox, Malik M. Khurram S. Khan, Sandra E. Zaeh, Michelle N. Eakin, Kristen L. Veraldi, Stuart S. Kassan, Peter H. Lenz, Daniel J. Wallace, Evelyn J. Bromet, Edward L. Treadwell, Robert F. Spiera, Adrian Shifren, Theresa Lawrence Ford, W. Neal Roberts, Jacqueline O’Toole, Senada Arabelovic, Matthew Koslow, Janet Lewis, Philip Cohen, Rebecca C. Keith, Thomas G. Osborn, Sarah Schafer, Justin C. Hewlett, Paul F. Dellaripa, Scott Zashin, Ruben Peredo-Wende, Chokkalingam Siva, Jay H. Ryu, Jeffrey J. Swigris, Lee Daugherty Biddison, Cynthia S. Rand, Barbara Segal, Daniel Small, Gerald W. Staton, Thomas Grader-Beck, Ghaith Noaiseh, Frederick B. Vivino, Tracy Luckhardt, James Gagermeier, Robert W. Ward, James Topilow, Kirsten Koons, Gabriel T. Bosslet
Publikováno v:
Chest. 159:733-742
Background The prevalence of burnout and depressive symptoms is high among physician trainees. Research Question What is the burden of burnout and depressive symptoms among fellows training in pulmonary and critical care medicine (PCCM) and what are
Autor:
Jamie Perin, Susan A. Robinson, Berkan Armagan, Adriana Bazoberry, Esen K. Akpek, Jean Kim, Thomas Grader-Beck, Alan N. Baer
Publikováno v:
Arthritis careresearch. 74(9)
OBJECTIVES To assess anti-Ro52 and anti-Ro60 serologic profiles as markers of clinically relevant phenotypic subsets of patients with Sjogren's syndrome (SS). METHODS From a cohort of 839 consecutive patients with suspected or established SS seen in
Autor:
Robert J Moots, Athena Papas, Thomas Dörner, Benjamin A Fisher, Salvatore De Vita, Thomas Grader-Beck, Simon J. Bowman, Wolfgang Hueber, Monika Sopala, Filipe Barcelos, Hendrik Schulze-Koops, Guido Junge, Wen-Lin Luo, J. Woznicki, Robert I. Fox, Xavier Mariette
Publikováno v:
Lancet (London, England). 399(10320)
Sjögren's syndrome is an autoimmune disease characterised by dry eyes and mouth, systemic features, and reduced quality of life. There are no disease-modifying treatments. A new biologic, ianalumab (VAY736), with two modes of suppressing B cells, ha
Autor:
Robert J Moots, Monika Sopala, Wolfgang Hueber, Xavier Mariette, S. De Vita, Wen-Lin Luo, Hendrik Schulze-Koops, Benjamin A Fisher, Guido Junge, Thomas Grader-Beck, Thomas Dörner, Simon J. Bowman, J. Woznicki, Filipe Barcelos, Athena Papas, Robert I. Fox
Publikováno v:
Annals of the Rheumatic Diseases. 80:593-594
Background:Sjogren’s syndrome (SS) is an autoimmune disease affecting excretory glands and characterised by B-cell hyperactivity. Ianalumab (VAY736) is a human monoclonal antibody to B-cell activating factor receptor, engineered for direct ADCC-med
Autor:
Thomas Grader-Beck, Michael Wu, Uzma Haque, Ashley Ingolia, Homa Timlin, Duvuru Geetha, Marilyn C. Towns, Monica Crespo-Bosque
Publikováno v:
Cureus
Introduction The use of hydralazine has been associated with the development of lupus erythematosus and lupus-like syndromes. We performed this retrospective study to identify clinical characteristics of individuals who developed hydralazine-induced